Document is current

Any future updates will be listed below

Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial

Crossref DOI link: https://doi.org/10.1186/s12885-023-11270-x

Published Online: 2023-08-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark